Kjell Magne Tveit

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Kjell Magne Tveit, Tormod Kyrre Guren, Bengt Glimelius et al. · Journal of Clinical Oncology · 2012 · 530 citations

Medicine, Oncology, Pharmacology +16

Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality

Øyvind Holme, Magnus Løberg, Mette Kalager et al. · JAMA · 2014 · 432 citations

Medicine, Population Health Sciences, Preventive Medicine +17

Late Side Effects and Quality of Life After Radiotherapy for Rectal Cancer

Kjersti Bruheim, Marianne G. Guren, Eva Skovlund et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 285 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men

Øyvind Holme, Magnus Løberg, Mette Kalager et al. · Annals of Internal Medicine · 2018 · 162 citations · Full text

Medicine, Oncology, Preventive Medicine +15

Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study

Johan N. Wiig, Kjell Magne Tveit, Jan Peter Poulsen et al. · Radiotherapy and Oncology · 2002 · 110 citations

Medicine, Oncology, Surgery +15